Cargando…
重组人凝血因子Ⅶa治疗血液病患者出血的临床疗效分析
OBJECTIVE: To investigate the treatment efficacy of recombinant activated factor Ⅶ (rFⅦa) for bleeding among patients with hematologic disorders. METHODS: A total of 38 times of bleeding in 31 patients with hematological disease treated with rFⅦa were analyzed retrospectively. RESULTS: The clinical...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
Editorial office of Chinese Journal of Hematology
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7354194/ https://www.ncbi.nlm.nih.gov/pubmed/28565741 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2017.05.011 |